Form 4: Biohaven Ltd. Chief Scientific Officer, Bruce Car, Reports Acquisition of 30,000 Common Shares
SEC Form 4 Filing
Bruce Car, Chief Scientific Officer of Biohaven Ltd., reports the acquisition of 30,000 common shares at a price of $33.583 per share on June 17, 2024.
Summary
- On June 17, 2024, Bruce Car, the Chief Scientific Officer of Biohaven Ltd., acquired 30,000 common shares of the company.
- The shares were purchased at a price of $33.583 per share.
- Following the transaction, Car directly owns 2,383 common shares and indirectly owns 30,000 common shares through an IRA.
- The direct holdings include shares acquired through the Biohaven Employee Share Purchase Plan (ESPP) on May 31, 2023 (305 shares), November 30, 2023 (1,336 shares), and May 31, 2024 (742 shares).
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The acquisition of shares by a high-ranking officer is generally a positive sign, but the document itself is simply a regulatory filing.
Positives
- The acquisition of a significant number of shares by a high-ranking officer may signal confidence in the company's future prospects.
Industry Context
Insider buying is often seen as a positive sign, suggesting that those with the most knowledge of the company believe its stock is undervalued or that positive developments are on the horizon. However, it's just one factor among many to consider when evaluating a company's prospects.
Key Dates
| Date | Description |
|---|---|
| May 31, 2023 | 305 shares acquired through the Biohaven Employee Share Purchase Plan (ESPP) |
| November 30, 2023 | 1,336 shares acquired through the ESPP |
| May 31, 2024 | 742 shares acquired through the ESPP |
| June 17, 2024 | Transaction date: Bruce Car acquired 30,000 common shares at $33.583 per share |
| June 20, 2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.